A review of neurocognitive and behavioral profiles associated with 22q11 deletion syndrome: Implications for clinical evaluation and treatment

Current Psychiatry Reports

Volumn 9, Issue 2, 2007, Pages 148-158

  Ousley, Opal ^a   Rockers, Kimberly ^b   Dell, Mary Lynn ^b   Coleman, Karlene ^b   Cubells, Joseph F ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; CALCIUM; CLOZAPINE; FLUOXETINE; LAMOTRIGINE; LITHIUM; MOOD STABILIZER; NEUROLEPTIC AGENT; PSYCHOSTIMULANT AGENT; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; VALPROIC ACID; VITAMIN D;

ADOLESCENCE; ADULTHOOD; ANXIETY DISORDER; ATTENTION DEFICIT DISORDER; ATTENTION DISTURBANCE; AUTISM; BEHAVIOR DISORDER; CHILD DEVELOPMENT; CHROMOSOME 22Q; CHROMOSOME DELETION; CHROMOSOME DISORDER; CLEFT PALATE; CLINICAL FEATURE; COGNITIVE DEFECT; COGNITIVE DEVELOPMENT; CONGENITAL HEART MALFORMATION; DEPRESSION; DEVELOPMENTAL DISORDER; DRUG DOSE TITRATION; DYSTONIA; FACE DYSMORPHIA; GENETIC COUNSELING; HUMAN; HYPOCALCEMIA; HYPOPARATHYROIDISM; IMMUNE DEFICIENCY; IMPULSIVENESS; INTELLECTUAL IMPAIRMENT; LANGUAGE DISABILITY; LEARNING DISORDER; MENTAL DEFICIENCY; MOOD DISORDER; MOTOR DYSFUNCTION; NEUROPSYCHOLOGICAL TEST; OBSESSIVE COMPULSIVE DISORDER; OCULOGYRIC CRISIS; PARATHYROID DISEASE; PATIENT EDUCATION; PERIODIC MEDICAL EXAMINATION; PHARYNX DISEASE; PSYCHOSIS; REVIEW; SCHIZOPHRENIA; THYMUS APLASIA; TOOTH MALFORMATION;

EID: 34147203757     PISSN: 15233812     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11920-007-0085-8     Document Type: Review

References (67)

1. Botto LD, May K, Fernhoff PM, et al.: A population-based study of the 22q11.2 deletion: phenotype, incidence, and contribution to major birth defects in the population. Pediatrics 2003, 112:101-107.
2. Oskarsdottir S, Vujic M, Fasth A: Incidence and prevalence of the 22q11 deletion syndrome: a population-based study in Western Sweden. Arch Dis Child 2004, 89:148-151.
3. Robin N, Shprintzen RJ: Defining the clinical spectrum of deletion 22q11.2. J Pediatr 2005, 147:90-96.
4. Antshel K, Kates W, Roizen N, et al.: 22Q11.2 deletion syndrome: genetics, neuroanatomy and cognitive/behavioral features. Child Neuropsychol 2005, 11:5-19.
5. Driscoll DA, Spinner NB, Budarf ML, et al.: Deletions and microdeletions of 22q11.2 in velo-cardio-facial syndrome. Am J Med Genet 1992, 44:261-268.
6. Scambler PJ, Carey AH, Wyse RK, et al.: Microdeletions within 22q11 associated with sporadic and familial DiGeorge syndrome. Genomics 1991, 10:201-206.
7. Scambler PJ, Kelly D, Lindsay E, et al.: Velo-cardio-facial syndrome associated with chromosome 22 deletions encompassing the DiGeorge locus. Lancet 1992, 339:1138-1139.
8. Online Mendelian Inheritance in Man #188400. Available at: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=OMIM. Accessed December 15, 2006.
9. Online Mendelian Inheritance in Man #192430. Available at: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=OMIM. Accessed December 15, 2006.
10. Goldmuntz E: DiGeorge syndrome: new insights. Clin Perinatol 2005, 32:963-978.
11. Eicher PS, McDonald-Mcginn DM, Fox CA, et al.: Dysphagia in children with a 22q11.2 deletion: unusual pattern found on modified barium swallow. J Pediatr 2000, 137:158-164.
12. Shprintzen RJ: The velo-cardio-facial syndrome: a distinctive behavioral phenotype. Ment Retard Dev Disabil Res Rev 2001, 6:142-147.
13. Beauchesne LM, Warnes CA, Connolly HM, et al.: Prevalence and clinical manifestations of 22q11.2 microdeletion in adults with selected conotruncal anomalies. J Am Coll Cardiol 2005, 45:595-598.
14. Murphy KC, Owen MJ: Schizophrenia, CATCH 22 and FISH. Br J Psychiatry 1996, 168:397-398.
15. Bassett AS, Hodgkinson K, Chow EW, et al.: 22q11 deletion syndrome in adults with schizophrenia. Am J Med Genet 1998, 81:328-337.
16. Bassett AS, Chow EW: 22q11 deletion syndrome: a genetic subtype of schizophrenia. Biol Psychiatry 1999, 46:882-891.
17. Usiskin SI, Nicolson R, Krasnewich DM, et al.: Velocardiofacial syndrome in childhood-onset schizophrenia. J Am Acad Child Adolesc Psychiatry 1999, 38:1536-1543.
18. Gerdes M, Solot C, Wang PP, et al.: Cognitive and behavioral profile of preschool children with chromosome 22q11.2 deletion. Am J Med Genet 1999, 85:127-133.
19. Lajiness-O'Neill R, Beaulieu I, Asamoah A, et al.: The neuropsychological phenotype of velocardiofacial syndrome (VCFS): relationship to psychopathology. Arch Clin Neuropsychol 2006, 21:175-184.
20. Sobin C, Kiley-Brabeck K, Daniels S, et al.: Neuropsychological characteristics of children with the 22Q11 deletion syndrome: a descriptive analysis. Child Neuropsychol 2005, 11:39-53.
21. Gothelf D, Eliez S, Thompson T, et al.: COMT genotype predicts longitudinal cognitive decline and psychosis in 22q11.2 deletion syndrome. Nat Neurosci 2005, 8:1500-1502.
22. Shprintzen RJ, Higgins AM, Antshel K, et al.: Velo-cardio-facial syndrome. Curr Opin Pediatr 2005, 17:725-730.
23. Swillen A, Feys H, Adriaens T, et al.: Early motor development in young children with 22q.11 deletion syndrome and conotruncal heart defect. Dev Med Child Neurol 2005, 47:797-802.
24. Solot CB, Knightly C, Handler SD, et al.: Communication disorders in the 22Q11.2 microdeletion syndrome. J Commun Disord 2000, 33:187-203.
25. Swillen A, Devriendt K, Legius E, et al.: Intelligence and psychosocial adjustment in velocardiofacial syndrome: a study of 27 children and adolescents with VCFS. J Med Genet 1997, 34:453-458.
26. Swillen A, Vandeputte L, Cracco J, et al.: Neuropsychological, learning, and psychosocial profile of primary school aged children with velo-cardio-facial syndrome (22q11 deletion): evidence for a nonverbal learning disability? Child Neuropsychol 1999, 5:230-241.
27. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, edn 4. Washington, DC: American Psychiatric Association; 1994.
28. Zinkstok J, Amelsvoort T: Neuropsychological profile and neuroimaging in patients with 22Q11.2 deletion syndrome: a review. Child Neuropsychol 2005, 11:21-37.
29. Wang P, Woodin M, Kreps-Falk R, Moss E: Research on behavioral phenotypes: velocardiofacial syndrome (deletion 22q11.2). Dev Med Child Neurol 2000, 42:422-427.
30. Moss E, Batshaw M, Solot C, et al.: Psychoeducational profile of the 22q11.2 microdeletion: a complex pattern. J Pediatr 1999, 134:193-198.
31. Bearden CE, Woodin MF, Wang PP: The neurocognitive phenotype of the 22q11.2 deletion syndrome: selective deficit in visual-spatial memory. J Clin Exp Neuropsychol 2001, 23:447-464.
32. Woodin M, Wang P, Aleman D, et al.: Neuropsychological profile of children and adolescents with the 22q11.2 microdeletion. Genet Med 2001, 3:34-39.
33. van Amelsvoort T, Henry J, Morris R, et al.: Cognitive deficits associated with schizophrenia in velo-cardio-facial syndrome. Schizophr Res 2004, 70:223-232.
34. Fine SE, Weissman A, Gerdes M, et al.: Autism spectrum disorders and symptoms in children with molecularly confirmed 22q11.2 deletion syndrome. J Autism Dev Disord 2005, 35:461-470.
35. Niklasson L, Rasmussen P, Oskarsdottir S, Gillberg C: Neuropsychiatric disorders in the 22q11 deletion syndrome. Genet Med 2001, 3:79-84.
36. Vorstman JA, Morcus ME, Duijff SN, et al.: The 22q11.2 deletion in children: high rate of autistic disorders and early onset of psychotic symptoms. J Am Acad Child Adolesc Psychiatry 2006, 45:1104-1112.
37. Antshel KM, Aneja A, Strunge L, et al.: Autistic spectrum disorders in velo-cardio facial syndrome (22q11.2 deletion). J Autism Dev Disord 2006 [Epub ahead of print].
38. Zagursky K, Weller RA, Jessani N, et al.: Prevalence of ADHD in children with velocardiofacial syndrome: a preliminary report. Curr Psychiatry Rep 2006, 8:102-107.
39. Golding-Kushner KJ, Weller G, Shprintzen RJ: Velo-cardio-facial syndrome: language and psychological profiles. J Craniofac Genet Dev Biol 1985, 5:259-266.
40. Gothelf D, Lombroso PJ: Genetics of childhood disorders: XXV. Velocardiofacial syndrome. J Am Acad Child Adolesc Psychiatry 2001, 40:489-491.
41. Feinstein C, Eliez S, Blasey C, Reiss AL: Psychiatric disorders and behavioral problems in children with velocardiofacial syndrome: usefulness as phenotypic indicators of schizophrenia risk. Biol Psychiatry 2002, 51:312-318.
42. Murphy K, Jone L, Owen M: High rates of schizophrenia in adults with velo-cardio-facial syndrome. Arch Gen Psychiatry 1999, 56:940-945.
43. White P, Chant D, Edwards N, et al.: Prevalence of intellectual disability and comorbid mental illness in an Australian community sample. Aust N Z J Psychiatry 2005, 39:395-400.
44. Weller EB, Rowan A, Elia J, Weller RA: Aggressive behavior in patients with attention-deficit/hyperactivity disorder, conduct disorder, and pervasive developmental disorders. J Clin Psychiatry 1999, 60(Suppl 15):5-11.
45. Williams NM, Owen MJ: Genetic abnormalities of chromosome 22 and the development of psychosis. Curr Psychiatry Rep 2004, 6:176-182.
46. Baker KD, Skuse DH: Adolescents and young adults with 22q11 deletion syndrome: psychopathology in an at-risk group. Br J Psychol 2005, 186:115-120.
47. Debbane M, Glaser B, David MK, et al.: Psychotic symptoms in children and adolescents with 22q11.2 deletion syndrome: neuropsychological and behavioral implications. Schizophr Res 2006, 84:187-193.
48. Cornblatt BA: The New York high risk project to the Hillside recognition and prevention (RAP) program. Am J Med Genet 2002, 114:956-966.
49. McGorry PD, McKenzie D, Jackson HJ, et al.: Can we improve the diagnostic efficiency and predictive power of prodromal symptoms of schizophrenia? Schizophr Res 2000, 42:91-100.
50. Carlson C, Papolos D, Pandita RK, et al.: Molecular analysis of velo-cardio-facial syndrome in patients with psychiatric disorders. Am J Hum Genet 1997, 60:851-859.
51. Arnold PD, Siegel-Bartelt J, Cytrynbaum C, et al.: Velo-cardio-facial syndrome: implications of microdeletion 22q11 for schizophrenia and mood disorders. Am J Med Genet 2001, 105:354-362.
52. Papolos DF, Faedda GL, Veit S, et al.: Bipolar spectrum disorders in patients diagnosed with velo-cardio-facial syndrome: Does a hemizygous deletion of chromosome 22q11 result in bipolar affective disorder? Am J Psychiatry 1996, 153:1541-1547.
53. Pulver AE, Nestadt G, Goldberg R, et al.: Psychotic illness in patients diagnosed with velo-cardio-facial syndrome and their relatives. J Nerv Ment Dis 1994, 182:476-478.
54. Antshel KM, Fremont W, Roizen NJ, et al.: ADHD, major depressive disorder, and simple phobias are prevalent psychiatric conditions in youth with velocardiofacial syndrome. J Am Acad Child Adolesc Psychiatry 2006, 45:596-603.
55. Gerdes M, Solot C, Wang P, et al.: Taking advantage of early diagnosis: preschool children with the 22q11.2 deletion. Genet Med 2001, 3:40-44.
56. Solot C, Gerdes M, Kirschner R, et al.: Communication issues in 22q11.2 deletion syndrome: children at risk. Genet Med 2001, 3:67-71.
57. Ramey C, Ramey SL: Early intervention and early experience. Am Psychol 1998, 53:109-120.
58. Stone WL, Yoder PJ: Predicting spoken language level in children with autism spectrum disorders. Autism 2001, 5:341-361.
59. National Research Council: Educating Children with Autism. Committee on Educational Interventions for Children with Autism. Washington, DC: Division of Behavioral and Social Sciences and Education; 2001.
60. Blomquist KB: Health, education, work, and independence of young adults with disabilities. Orthop Nurs 2006, 25:168-187.
61. Gothelf D, Frisch A, Munitz H, et al.: Clinical characteristics of schizophrenia associated with velo-cardio-facial syndrome. Schizophr Res 1999, 35:105-112.
62. Debbane M, Glaser B, David MK, et al.: Psychotic symptoms in children and adolescents with 22q11.2 deletion syndrome: neuropsychological and behavioral implications. Schizophr Res 2006, 84:187-193.
63. Scuccimarri R, Rodd C: Thyroid abnormalities as a feature of DiGeorge syndrome: a patient report and review of the literature. J Pediatr Endocrinol Metab 1998, 11:273-276.
64. Murphy KC: Annotation: velo-cardio-facial syndrome. J Child Psychol Psychiatry 2005, 46:563-571.
65. Papolos DF, Faedda GL, Veit S, et al.: Bipolar spectrum disorders in patients diagnosed with velo-cardio-facial syndrome: Does a hemizygous deletion of chromosome 22q11 result in bipolar affective disorder? Am J Psychiatry 1996, 153:1541-1547.
66. Gothelf D, Presburger G, Zohar AH, et al.: Obsessive-compulsive disorder in patients with velocardiofacial (22q11 deletion) syndrome. Am J Med Genet B Neuropsychiatr Genet 2004, 126:99-105.
67. Karayiorgou M, Morris MA, Morrow B, et al.: Schizophrenia susceptibility associated with interstitial deletions of chromosome 22q11. Proc Natl Acad Sci U S A 1995, 92:7612-7616.